1-iodo-4-methoxybenzene CAS:696-62-8

1-iodo-4-methoxybenzene

Chemical Name:    1-iodo-4-methoxybenzene
CAS.NO: 696-62-8
Synonyms: Benzene, 1-iodo-4-methoxy-
p-Iodoanisole
Anisole,p-iodo
p-methoxyiodobenzene;
4-Iodoanisole
 
Molecular Formula: C7H7IO
Molecular Weight: 234.03400
 
Physical and Chemical Properties:
Density: 1.727 g / cm3
Boiling point: 237 ° C726 mm Hg (lit.)
Melting point: 50-53 ° C (lit.)
Flash point:> 230 ° F
Refractive index: 1.591
 
Specification:
Appearance:Light yellow solid
Purity:>99.5%
 
Packing:20kg / cardboard drum, can also be packaged according to customer requirements
Storage:Store in a cool, dry, well-ventilated warehouse. Keep away from fire and heat sources. Protect from direct sunlight. Packaging is sealed. It should be stored separately from acids and edible chemicals.
Application: Applicationd as OLED intermediate



Pls send inquiry to info@nbinno.com if you have any interests, thank you!


Related News: Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.6,7-Dimethoxyquinolin-4-ol CAS:13425-93-9 Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.2'-Deoxycytidine-5'-monophosphate disodium salt Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.5,8-dibromobenzo[c]phenanthrene CAS:121012-73-5 Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).